Information  X 
Enter a valid email address

Broker Forecast - Liberum Capital issues a broker note on Clinigen Group

By BFN News | 09:30 AM | Wednesday 26 February, 2020

Liberum Capital today upgrades its investment rating on Clinigen Group (LON:CLIN) to hold (from sell) and cut its price target to 790p (from 820p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t